Osteri 750mcg Solution for Injection
By Osteri
Rx
3ml Solution for Injection in a Pre-filled pen

Composition
Teriparatide(750mcg)

Manufacturer - Emcure Pharmaceuticals Ltd
255/2, Hinjawadi, Pune - 411057, India

Expires on or after
August, 2025

liver
Limited information is available regarding the use of Osteri 750mcg Solution for Injection in individuals with liver disease. It is important to consult your doctor before using this medication if you have liver-related concerns. Your healthcare provider can provide guidance based on your specific medical condition.

kidney
Caution should be taken when using Osteri 750mcg Solution for Injection in patients with kidney disease. Adjustments to the dosage may be necessary, so it is important to consult your doctor. Avoid using this medication in severe kidney disease cases.

alcohol
When taking Osteri 750mcg Solution for Injection, it is important to be cautious when consuming alcohol. It is recommended to consult your doctor regarding alcohol intake.

driving
Osteri 750mcg Solution for Injection can lower alertness, impact vision, and cause drowsiness or dizziness. Avoid driving if experiencing these effects.

pregnancy
During pregnancy, it's important to know that Osteri 750mcg Solution for Injection may not be safe to use. Animal studies indicate potential harm to the baby. Consult your doctor for a thorough evaluation of benefits versus risks before using this medication.

breastfeeding
Safety advice for breastfeeding while using Osteri 750mcg Solution for Injection is unavailable. Consult your doctor for guidance.
Habit Forming | No |
Chemical Class | Parathyroid Hormone Analogs |
Therapeutic Class | - |
Action Class | Bone formation stimulator -PTH analogue |
₹10848
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 11-Feb-2025